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Interventional Cardiology
MRI Can Predict Functional Recovery
After Opening of Chronic Total Occlusions
Improvements in catheter design and the use of drug-eluting stents have reduced thecomplication rates for interventions on chronic total occlusions (CTOs), but
questions remain as to which patients will benefit from intervention. In this study,
contrast enhanced MRI (ce-MRI) was performed before and after intervention
on arteries that were known to be occluded for at least six weeks. On average,
there were slight improvements in systolic volume indexes and no change in
ejection fraction. The greatest improvements were seen when 25% of the
wall thickness showed delayed enhancement (evidence of previous infarction);
there was no improvement if more than 75% had delayed enhancement. This
study suggests that ce-MRI may be useful in predicting the therapeutic
recovery of contraction. See page 721. See figure.
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Acute Coronary Syndromes
Similar Efficacy for ACE-I and ARB in Reducing Cardiovascular Events
Several studies have shown that angiotensin-converting enzyme inhibitors (ACE-I)reduce the frequency of myocardial infarctions (MIs). The data for angiotensin
receptor blockers (ARB) are less clear, with conflicting results. The VALIANT trial
enrolled over 14,000 subjectswith recentMI andheart failure to captopril, valsartan, or
both. McMurray and colleagues studied the rates of recurrent vascular events and
report that therewas no difference in the frequency ofMI or total cardiovascular events
by protocol medication. Although there was no placebo arm in this study, this study
suggests that captopril and valsartan are equally effective in preventing recurrent
cardiovascular events. See page 726. See figure.
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Heart Failure
Diastolic Wall Stress is the Best Predictor of BNP Level
While elevated B-type natriuretic peptide (BNP) is a reliable indicator for con-gestive heart failure (CHF), the stimulus for its release from cardiac myocytes
remains poorly understood. Additionally, there can be large differences in absolute
BNP levels among patients with similar clinical pictures. Iwanaga and colleagues
measured BNP levels in 160 patients with CHF and compared these with multiple
measurements obtained through cardiac catheterization and echocardiography. B-type
natriuretic peptide was only weakly correlated with left ventricular filling pressure and
ejection fraction, but strongly correlated with diastolic wall stress. Diastolic wall stress
is a calculated number that incorporates not only the end-diastolic pressure but also the
internal diameter and wall thickness of the ventricle. This study helps to explain the
absolute differences in BNP levels in patients with similar filling pressures and ejection
fractions and also sheds light on the stimulus for BNP production and release from
myocytes. See page 742. See figure.
(continued) A-42Heart Rhythm Disorders
Statin Use Associated with Reduced Ventricular Arrhythmias
Statins have been shown to have multiple salutary effects on cardiac morbidity. Inaddition to preventing future myocardial infarctions, there is some experimental
evidence to suggest that statins may exert a membrane-stabilizing effect on cardiac
myocytes thatmight reduce ventricular arrhythmias (VA). Vyas and colleagues studied
the effect of statinuse onVAs in subjects enrolled in theMADITtrialwhohad ahistory
ofmyocardial infarction, an ejection fraction30%, andwhowere randomized to the
implantable cardioverter-defibrillator arm. Subjects taking statins had a 30%reduction
in the frequency ofVAs.This relationshipwas found to be bothdose-dependent and to
be present within a few days of starting therapy. It is unknown if the effect was due to
decreased episodes of ischemia or to a direct membrane-stabilizing effect on the
myocytes. This study adds another potential mechanism via which statins improve
mortality in patients with coronary artery disease. See page 769.
Cardiac Imaging
Speckle Tracking Echocardiography Can Measure Myocardial Strain
TissueDoppler imaging canmeasure intramyocardial wall velocities, but it is mostaccurate when the wall is moving perpendicular to the Doppler angle. Speckle
tracking echocardiography uses speckle patterns created by the interference of the
ultrasound beams and the myocardium. These speckles are fairly stable and can be
tracked as the wall moves throughout the cardiac cycle. Strain is a measurement of
deformation; it is calculated bymeasuring the distance between twoobjects at a specific
time period divided by the distance at baseline. Amundsen and colleagues developed a
unique software package to calculate strain based on speckle tracking echocardiogra-
phy; in this study they compared these measurements to sonomicrometry in anesthe-
sized dogs and to magnetic resonance imaging in humans. They report excellent
correlations with both techniques. This technique appears to offer an angle-
independent method for measuring myocardial strain. See page 789.
